<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03214835</url>
  </required_header>
  <id_info>
    <org_study_id>CDx Laryngeal and LPR Study</org_study_id>
    <nct_id>NCT03214835</nct_id>
  </id_info>
  <brief_title>CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions</brief_title>
  <official_title>CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CDx Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rambam Health Care Campus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>CDx Diagnostics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will take place at Rambam medical center, department of Otolaryngology Head and
      Neck Surgery, for two years. Patients suspected of LPR or laryngeal l tumor and are candidate
      for laryngeal or hypopharyngeal biopsies will be recruited.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      First- all patients visiting our clinic with laryngeal complaints suspicious for either LPR
      or laryngeal tumor will fill the RSI questionnaire. Then fiberoptic examination will be
      performed by a laryngologist that will complete the RFS score.

      Patients with suspicious lesions will be referred for TFL standard biopsy and CDx brush
      biopsy in order to determine whether the lesions are malignant or benign. The pathologic
      diagnosis of invasive carcinoma from a TFL biopsy is considered equivalent to the pathology
      results from a direct laryngoscopy biopsy. All patients with benign pathology or carcinoma
      in-situ (CIS) on TFL biopsy will be referred for subsequent direct laryngoscopy (DL) for
      definitive diagnosis. At the time of the DL biopsy will include also another CDx brush smear.
      Patients with benign-appearing lesions will be taken for lesion removal and biopsy.Before
      removal of the lesion a CDx brush smear will be collected.

      All the participants suspected of LPR will have: PHmetry with Manometry andCDx brush
      biopsy.All relevant demographic and clinical data will be retrieved for analysis.

      CDx biopsies will be an addition to the routine management of the patients in the diagnosis
      and follow-up of laryngeal lesions and LPR and will not replace the standard regimen.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2018</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Screening</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy of EndoCDx brush</measure>
    <time_frame>3 months</time_frame>
    <description>Efficacy of EndoCDx brush biopsy as a diagnostic tool for laryngeal lesions compared to cup forceps biopsy and a diagnostic tool for LPR compared to double probe PH monitoring</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assessment of pain</measure>
    <time_frame>6 months</time_frame>
    <description>Assessment of pain during EndoCDx brush biopsy under local anesthesia by Visual Analog Score for pain</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Laryngeal Disease</condition>
  <condition>Laryngeal Tumor</condition>
  <condition>Laryngopharyngeal Reflux</condition>
  <arm_group>
    <arm_group_label>Brush biopsy for laryngeal lesion</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brush biopsy of the larynx - in addition to the standard biopsy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Brush biopsy for LPR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brush biopsy of the larynx at the post cricoid region - in addition to the standard examination for LPR (PH monitoring double probe)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Endo CDx Brush biopsy</intervention_name>
    <description>In patients with laryngeal lesion the brush biopsy will be taken with the standard cup biopsy - either in the clinic or in the OR. In LPR patients brush biopsy will be taken in the clinic.</description>
    <arm_group_label>Brush biopsy for laryngeal lesion</arm_group_label>
    <arm_group_label>Brush biopsy for LPR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 or over

          -  patients suspected to suffer from LPR

          -  Patients with laryngeal/hypopharyngeal lesions.

        Exclusion Criteria:

          -  Patient refusal

          -  Patients with anatomical variants which precludes biopsy taking.

          -  Patients with allergy to lidocain-based local anesthesia agents.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jacob Cohen, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rambam Health Care Campus</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Limor Benyamini, MD</last_name>
    <phone>1700505150</phone>
    <email>info@rambam.health.gov.il</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jacob Cohen, MD</last_name>
    <phone>047772480</phone>
  </overall_contact_backup>
  <verification_date>January 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 10, 2017</study_first_submitted>
  <study_first_submitted_qc>July 10, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 12, 2017</study_first_posted>
  <last_update_submitted>January 23, 2018</last_update_submitted>
  <last_update_submitted_qc>January 23, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">January 25, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Larynx</keyword>
  <keyword>reflux</keyword>
  <keyword>LPR</keyword>
  <keyword>tumor</keyword>
  <keyword>lesion</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
    <mesh_term>Laryngopharyngeal Reflux</mesh_term>
    <mesh_term>Laryngeal Diseases</mesh_term>
    <mesh_term>Laryngeal Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

